Editorial Board

Editor-in-Chief

Gerhard Kostner

Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.

Interests: Lipoprotein (a) [Lp(a)]; Lipoprotein metabolism; Atherosclerosis; Lipid oxidation; Transcriptional regulation; MicroRNA; Type 2 diabetes mellitus (T2DM)​

Email: gerhard.kostner@medunigraz.at

Honorary Editor

Gerd Utermann

Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.

Interests: Human genetics; Genetic epidemiology; Apolipoprotein E polymorphism; Apolipoprotein(a) size polymorphism; Lipoprotein (a) [Lp(a)]; Cardiovascular disease; Hyperlipoproteinemia type III; Mendelian randomization; Plasma lipoprotein concentrations; Genetic risk factors

Editorial Board Members

Michael B. Boffa

Department of Biochemistry and Robarts Research Institute, The University of Western Ontario, London, ON, Canada.

Interests: Lipoprotein (a); TAFI; Fibrinolysis; Thrombosis; Cardiovascular disease; Atherosclerosis; Cancer metastasis; Protein biochemistry; Enzyme regulation

Zhenyue Chen

Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Interests: Atherosclerosis; Lipid metabolism; Metabolic cardiovascular disease; Translational cardiology; Small-molecule screening

Robert Clarke

Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Interests: Cardiovascular epidemiology; Lipid-related risk factors; Genetic epidemiology; Stroke; Ischaemic heart disease; Biomarkers; Risk prediction

Christa M. Cobbaert

The Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Centre, Leiden, The Netherlands.

Interests: Precision diagnostics; Clinical proteomics; Metrology; Standardization and harmonization of medical tests; Lipoprotein(a) test standardization using a mass spectrometry-based reference measurement procedure; P4 medicine; Cardiovascular risk management; Kidney disease biomarkers; Cancer biomarkers; Mass spectrometry-based protein diagnostics; Regulatory affairs in laboratory medicine

Mariko Harada-Shiba

Department of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center Hospital, 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan.

Interests: Lipidology; Gene therapy; Molecular biology

Karam Kostner

Department of Cardiology, Mater Hospital, University of Queensland, Brisbane, QLD, Australia.

Interests: Preventive cardiology; Lipid disorders; Lipoprotein (a); Cholesterol-lowering therapies; Cardiovascular disease; Atherosclerosis; Lipid clinics; Clinical trials; Lipidology; Public health policy; Medical education

Gilles Lambert

DéTROI Research Unit, INSERM UMR1188, University of La Réunion Medical School, Saint-Pierre, France.

Interests: PCSK9; LDL receptor; Lipoprotein (a); Familial hypercholesterolemia; Atherosclerosis; Lipoprotein metabolism; Cardiovascular disease; Therapeutic targeting of lipid pathways

Jian-Jun Li

State Key Laboratory of Cardiovascular Disease, Cardiometabolic Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Interests: Dyslipidemia; Inflammation; Atherosclerosis; Cardiovascular risk factors; Lipoprotein (a); Metabolic disease biomarkers; Coronary artery disease; Stroke; Geriatric cardiology

Santica Marcovina

Medpace Reference Laboratories, Cincinnati, OH, USA.

Interests: Lipoprotein (a); Apolipoproteins (apo AI, apo B); Monoclonal antibodies; Assay development; Method standardization; Clinical chemistry; Cardiovascular disease; Lipid standardization; Multi-center clinical trials

Sergei N. Pokrovsky

Department of Atherosclerosis, Institute of Experimental Cardiology, Cardiology Research Center, Moscow, Russia.

Interests: Atherosclerosis; Lipidology; Lipoprotein (a); Biomarkers;Therapeutic apheresis; Assay and treatment options development

Gissette Reyes-Soffer

Department of Preventive Medicine and Nutrition, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.

Interests: Lipid metabolism; Lipoprotein(a); NAFLD; Cardiovascular disease; Genetic mutations; Lipid-lowering therapy

Peter P.  Toth

Ciccarone Center for the Prevention of Heart Disease, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Interests: Lipidology; Preventive cardiology; Dyslipidemia; Atherosclerosis; Lipoprotein (a); Cardiovascular risk; LDL-C therapies

Sotirios Tsimikas

Department of Medicine, Division of Cardiology, University of California, La Jolla, San Diego, CA, USA.

Interests: Lipoprotein (a); Atherosclerosis; Oxidation-specific epitopes; Cardiovascular disease; Molecular imaging; Biomarkers; Biotheranostics; Translational medicine; Targeted therapeutics; Vascular medicine

Arnold von Eckardstein

Department of Laboratory Medicine, University Hospital Zurich, Zurich, Switzerland.

Interests: Structure; Function; Metabolism and clinical significance of lipoproteins; Risk factors and biomarkers of cardiovascular and metabolic diseases

Gerald F. Watts

Medical School, The University of Western Australia, Crawley, Perth, Australia.

Interests: Atherosclerosis; Diabetes; General medicine; Lipid metabolism

Submit a Manuscript

Aims and Scope

Author Instructions

Editorial Board By Country/Region

17 Editors in 11 countries/regions